In 2027, CMS says states can either immediately transition all Medicaid beneficiaries enrolled in the expansion population into six-month eligibility checks or, in a move beneficiary advocates would prefer, wait until a beneficiary’s eligibility is up for its annual renewal to switch to the new semi-annual redetermination.
FREE TRIAL Receive 30 days of no-obligation access. SIGN UP
Home
Top Story
Prasad Out At FDA, Turning Critics’ Focus Back To Makary
FDA’s polarizing and high-profile biologics chief Vinay Prasad is leaving the agency for the second time since his tenure began a year ago, and this time his departure may be permanent, after yet another controversy over rare disease approvals spilled into public view and cast new doubts on Prasad and Commissioner Marty Makary’s leadership.
Drug Pricing Deals In Spotlight
Democrats Ask Trump For Copies Of MFN Deals
Senior congressional Democrats are demanding President Donald Trump turn over unredacted copies of the administration’s “most favored nation” drug pricing agreements with pharmaceutical companies, after receiving no response from HHS Secretary Robert F. Kennedy Jr. to an earlier request for details.
Democrats Seek Details On GLOBE, GUARD, GENEROUS Models, Warn Of Pharma Deal Loopholes
Industry Urging Pfizer CEO To Fight MFN Codification Even As Deals Not Yet Finalized
Latest News
Using more than 15 independent program administrators and a nationwide network of pharmacies and telehealth platforms, Eli Lilly on Thursday (March 5) launched a new Employer Connect platform, a program aiming to expand discounted access to the manufacturer’s obesity medications -- including the GLP-1 Zepbound (tirzepatide) pen -- for employer-sponsored health plans.
As the Trump administration continues to highlight its work on food and nutrition ahead of the midterm elections, food stakeholders at the National Food Policy Conference this week voiced longstanding frustrations with the slow pace of federal government oversight, saying the lack of clear federal standards has pushed states to adopt their own patchwork of food regulations.
FDA granted its third approval under the Commissioner’s National Priority Review Voucher program to Johnson & Johnson for combination blood cancer therapy Tec-Dara Thursday (March 5), issuing the approval 55 days after the drug’s application was filed.
A new poll from the Annenberg Public Policy Center finds trust in public health agencies has fallen since the start of the Trump administration, despite messaging from HHS Secretary Robert F. Kennedy Jr. and his appointees that they are working to restore trust that was lost during the COVID-19 pandemic.